Year: 2020
Type: review
Abstract: Cardiovascular disease, which can lead to angina and shortness of breath, remains one of the most serious threats to human health. Owing to its imperceptible symptoms, it is difficult to determine the pathogenesis and treatment methods for cardiovascular disease. Nuclear factor erythropoietin-2-related factor 2/heme oxygenase 1 (Nrf2/HO-1) is a protein found in all cells of the human body. It is activated, transferred to the nucleus, and bound to DNA by antioxidant response elements (AREs). As a regulator of the antioxidant system, it upregulates the expression of HO-1 to reduce oxidative stress. Nrf2/HO-1 also has the ability to modulate calcium levels to prevent ferroptosis, pyroptosis, autophagy, programmed cell necrosis, alkaliptosis, and clockophagy. In view of the importance of Nrf2/HO-1 in the regulation of homeostasis, this review summarizes current research on the relationship between cardiovascular disease and Nrf2/HO-1. Normal cardiovascular diseases, such as viral myocarditis and myocardial ischemia-reperfusion injury, have been treated with Nrf2/HO-1. Rheumatic heart disease, cardiac tumors, arteriosclerosis, arrhythmia, hypertensive heart disease, and myocardial infarction have also been treated during experiments. Research has demonstrated the clinical application of Nrf2/HO-1 in pediatric cardiovascular disease; further clinical trials will help elucidate the potential of the Nrf2/HO-1 signaling axis.
Source: Cardiology Research and Practice
DOI: 10.1155/2020/5695723
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: Nrf2/HO-1 pathway, heme oxygenase-1, cardiovascular disease, oxidative stress, antioxidant response element, ferroptosis, pyroptosis, autophagy, myocardial ischemia-reperfusion injury, viral myocarditis, myocardial infarction, hypertensive heart disease, cardiac arrhythmias, arteriosclerosis, cardiac tumor, rheumatic heart disease, pediatric cardiovascular disease, therapeutic target
Open Access status: gold
Estimated APC paid: $2,570
Awards: G1282082443, G1328900800, G1920625089, 水凝胶载体移植造血干细胞治疗心肌梗死的新方法, G3224159403, G3713587377, G3866267345, G4009089751, G4162992566, G4182924375, 新型保存液SS-Ⅱ液通过Nrf2/HO-1/Ferroptosis信号轴发挥心肌保护功能的机制研究, G4578640218, G4812808795, G4827839812, G5063549464, G5624183911, G5774300643, G600165546, G6016115277, G7084710161, G7215419555, G8689805540, G8749814800, G8755559316
OpenAlex ID: W3004239978
